Sentinel node biopsy for breast cancer: Showtime or dress rehearsal?

In Vivo

Volumn 14, Issue 1, 2000, Pages 255-264

  Moffat Jr , Frederick L ^a,c   Ashikaga, Takamaru ^b   Krag, David N ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Gamma detection probes; Isosulfan blue dye; Lymphoscintigraphy; Radiocolloids; Sentinel lymph node biopsy

Indexed keywords

BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; HUMAN; IN VIVO STUDY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; PNEUMOTHORAX; REVIEW;

EID: 0343184007     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Ravdin PM, De Laurentiis M, Vendely T, Clark GM: Prediction of axillary lymph node status in breast cancer patients by use of prognostic factors. J Natl Cancer Inst 86: 1771-1774, 1994.
2. Donegan WL: Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 47:28-51, 1997.
3. Krag DN Minimal access surgery for staging regional lymph nodes: the sentinel node concept. Curr Probl Surg 35: 951-1018, 1998.
4. Gulec SA, Moffat FL, Carroll RG: The expanding clinical role for intraoperative gamma probes. In: Nuclear Medicine Annual 1997 (Freeman LM, ed.). Philadelphia, Lippincott- Raven, 1997, pp. 209-237.
5. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Boom RPA, van Diest PJ, et al: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38: 366-368, 1997.
6. Albertini JJ, Cruse CW, Rapaport D, et al: Intraoperative radiolymphoscintigraphy improves sentinel node identification in patients with melanoma. Ann Surg 223: 217-224, 1996.
7. Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol 2: 335-340, 1993.
8. Krag DN, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer. A multicenter validation study. New Engl J Med 339: 941-946, 1998.
9. Veronesi U, Paganelli G, Viale G, et al: Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91: 368-373, 1999.
10. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patients with breast cancer. J Amer Med Assoc 276: 1818-1822, 1996.
11. Reintgen DS, Joseph E, Lyman GH, et al: The role of selective lymphadenectomy in breast cancer. Cancer Control (MCC) 4: 211-219, 1997.
12. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 349: 1668-1669, 1997.
13. Veronesi U, Paganelli G, Galimberti V, et al: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349: 1864-1867, 1997.
14. Krag DN, Ashikaga T, Harlow SP, Weaver DL: Development of sentinel node targeting technique in breast cancer patients. Breast J 4: 67-74, 1998.
15. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391-401, 1994.
16. Giuliano AE, Dale PS, Turner RR, et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222: 394-401, 1995.
17. Giuliano AE, Barth AM, Spivack B, Beitsch PD, Evans SW: Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Amer Coll Surg 183: 185-189, 1996.
18. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S: Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Amer Coll Surg 186: 275-283, 1998.
19. Offodile R, Hoh C, Barsky SH, et al: Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 82: 1704-1708, 1998.
20. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15: 2345-2350, 1997.
21. Cox CE, Pendas S, Cox JM, et al: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227: 645-653, 1998.
22. Morton DL, Wen D-R, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 27: 392-399, 1992.
23. Morton DL, Wen D-R, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 11: 1751-1756, 1993
24. Krag DN, Meijer SJ, Weaver DL, et al: Minimal-access surgery for staging of malignant melanoma. Arch Surg 130: 654-658, 1995.
25. Cabanas R: An approach for the treatment of penile carcinoma. Cancer 39: 456-466, 1977.
26. Harris JR, Osteen RT: Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5: 17-21, 1985.
27. Sosa JA, Diener-West M, Gusev Y: Association between extent of axillary lymph node dissection and survival in patients with Stage I breast cancer. Ann Surg Oncol 5: 140-149, 1998.
28. Veronesi U, Valagussa P: Inefficacy of internal mammary node dissection in breast cancer surgery. Cancer 46: 170-175, 1981.
29. Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy. Cancer 41: 1170-1178, 1978.
30. Morrow M, Foster RS Jr: Staging of breast cancer. A new rationale for internal mammary node biopsy. Arch Surg 116: 748-751, 1981.
31. Noguchi M, Ohta N, Koyasaki N, Taniya T, Miyazaki I, Mizukami Y: Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer 68: 1918-1925, 1991.
32. Noguchi M, Koyasaki N, Ohta N, et al: Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erbB-2 expression in patients with breast cancer. Arch Surg 128: 242-246, 1993.
33. Handley RS: Carcinoma of the breast (Bradshaw Lecture). Ann Roy Coll Surg Engl 57: 59-66, 1975.
34. Deemarski LY, Seleznev IK: Extended radical operations on breast cancer of medial or central location. Surgery 96: 73-77, 1984.
35. Veronesi U, CAscinelli N, Greco M, et al: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202: 702-707, 1985.
36. Cody HH III, Urban JA: Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 2: 32-37, 1995.
37. Krag DN, Harlow SP, Weaver DL, Ashikaga T: Technique of selected resection of radiolabeled lymph nodes in breast cancer patients. Semin Breast Dis 1: 111-116, 1998.
38. Moffat FL, Gulec SA, Sittler SY, Serafini AN, Sfakianakis GN, Boggs JE, et al: Unfiltered sulphur colloid and sentinel node biopsy for breast cancer: technical and kinetic consideMtions. Ann Surg Oncol 6: 746-755, 1999.
39. McMasters KM, Giuliano AE, Ross MI, et al: Sentinel lymph node biopsy for breast cancer - not yet the standard of care. New Engl J Med 339: 990-995, 1998.
40. De Cicco C, Cremonesi M, Chinol M, et al: Optimization of axillary lymphoscintigraphy to detect the sentinel node in breast cancer. Tumori 83: 539-541, 1997.
41. Galimberti V, Zurrida S, Zucali P, Luini A: Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? The Breast 7: 8-10, 1998.
42. Guenther JM, Krishnamoorthy M, Tan LR, et al: Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 3: 336-340, 1997.
43. Flett MM, Going JJ, Stanton PD, Cooke TG: Sentinel node localization in patients with breast cancer. Br J Surg 85: 991-993, 1998.
44. Alex JC, Krag DN: The gamma probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin North Am 5: 33-41, 1996.
45. Roumen RMH, Valkenberg JGM, Geuskens LM: Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 23: 495-502, 1997.
46. Crossin JA, Johnson AC, Stewart PB, Turner WW Jr: Gamma probe guided resection of the sentinel lymph node in breast cancer. Amer Surg 64: 666-668, 1998.
47. Miner TJ, Shriver CD, Jaques DP, Maniscalco-Theberge ME, Krag DN: Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol 5: 315-321, 1998.
48. Snider HS, Dowlatshahi K, Fan M, Bridger WM, Rayudu G, Oleske D: Sentinel node biopsy in the staging of breast cancer. Amer J Surg 176: 305-310, 1998.
49. Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS: Sentinel lymph node biopsy for staging breast cancer. Amer J Surg 176: 532-537, 1998.
50. Barnwell JM, Arredondo MA, Kollmorgen D, et al: Sentinel node biopsy in breast cancer. Ann Surg Oncol 5: 120-130, 1998.
51. Nwariaku FE, Euhus DM, Beitsch PD, et al: Sentinel lymph node biopsy: an alternative to elective axillary dissection for breast cancer. Amer J Surg 176: 529-531, 1998.
52. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al: Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Amer Coll Surg 186: 423-427, 1998.
53. Ollila DW, Giuliano AE: Intraoperative lymphatic mapping and sentinel lymphadenectomy using isosulfan blue dye. Breast Diseases 8: 297-300, 1998.
54. Hill ADK, Tran KN, Akhurst T, et al: Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 229: 528-535, 1999.
55. Cox CE, Haddad F, Bass S, et al: Lymphatic mapping in the treatment of breast cancer. Oncology 12: 1283-1298, 1998.
56. Gulec SA, Moffat FL, Carroll RG, et al: Sentinel lymph node localization in early breast cancer. J Nucl Med 39: 1388-1393, 1998.
57. Chu KU, Turner RR, Hansen NM, et al: Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229: 536-541, 1999.
58. International Ludwig Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 335: 1565-1568, 1990.
59. de Mascerel I, Bonichon F, Coindre JM, Trojani M: Prognostic significance of breast cancer axillary lymph node metastases assessed by two special techniques: re-evaluation with further follow-up. Br J Cancer 66: 523-527, 1992.
60. Sedmak DD, Meineke TA, Knechtges DS, Anderson J: Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 2: 516-520, 1989.
61. Byrne J, Horgan PH, England S, et al: A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma. Eur J Cancer 28: 658-660, 1992.
62. Hainsworth PJ, Tjandra JJ, Stilwell RG, et al: Detection and significance of occult metastases in node negative breast cancer. Br J Surg 80: 459-463, 1993.
63. McGuckin MA, Cummings MC, Walsh MD, et al: Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 71: 88-95, 1996.
64. Schreiber RH, Pendas S, Ku NN, et al: Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol 6: 95-101, 1999.
65. Clare SE, Sener SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ: Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 4: 447-451, 1997.
66. Wells CA, Heryet A, Brochier J, Gatter KC, Mason DY: The immunocytochemical detection of axillary micrometastases in breast cancer Br J Cancer 50: 193-197, 1984.
67. Bussolati G, Gugliotta P, Morra I, Pietribiasi F, Berardengo E: The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer 54: 631-636, 1986.
68. Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin D, Contesso G: Importance of tumor cells in axillary sinus margins ("clandestine" metastases) dislvered by serial sectioning in operable breast carcinoma. Acta Oncol 27: 483-487, 1988.
69. Smith B, Selby P, Southgate J, et al: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227-1229, 1991.
70. Wang X, Heller R, VanVoorhis N, et al: Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 220: 768-774, 1994.
71. Noguchi S, Aihara T, Nakamori S, et al: The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 74: 1595-1600, 1994.
72. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H: Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC-1 mRNA and Keratin-19 mRNA amplification. Amer J Pathol 148: 649-656, 1996.
73. Lockett MA, Baron PL, O'Brien PH, et al: Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase- polymerase chain reaction panel. J Amer Coll Surg 187: 9-16, 1998.
74. Mori M, Mimori K, Inoue H, et al: Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 55: 3417-3420, 1995.
75. Bestick PJ, Chatterjee S, Chi DD, et al: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632-2640, 1998.
76. Pelkey TJ, Frierson HF, Bruns DE: Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 42: 1369-1381, 1996.
77. Dixon JM, Mamman U, Thomas J, et al: Accuracy of intraoperative frozen-section analysis of axillary nodes. Br J Surg 86: 392-395, 1999.
78. Rubio IT, Korourian S, Cowan C, et al: Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 5: 689-694, 1998.
79. Klimberg VS, Westbrook KC, Korourian S: Intraoperative touch preps in breast cancer surgery. Ann Surg Oncol 5: 220-226, 1998.
80. Cox CE, Bass SS, Boulware D, Ku NK, Berman C, Reintgen DS, Implementation of a new surgical technique: outcome measures for lymphatic mapping of breast carcinoma. Abstract Book. 52nd Annual Cancer Symposium of the Society of Surgical Oncology, March 4-7, 1999, Orlando, FL, Abstract 51, Pp. 21.
81. McNeil C: Sentinel node biopsy: studies should bring needed data. J Natl Cancer Inst 90: 728-730, 1998.